The platform uses an ultrasensitive photonic biosensor based on silicon nitride waveguides and a nanocoating to enhance the sensitivity and reliability of microfluidic devices. This technology allows physicians to detect various biomarkers, including viruses, DNA, RNA, proteins, and other biomolecules. The photonic biosensor is a label-free technology that has the potential to detect multiple biomarkers simultaneously using light instead of electricity. Surfix aims to make diagnostics accessible to everyone and everywhere through their innovative platform.